Genetika+ is proud to be the winner of the Health Startup Challenge 2023! Thanks to Reuters Events for recognizing our work in precision medicine - check out the article to learn more about our collaboration with pharma to advance CNS drug development! linkedin.com/posts/reuterse…

Looking forward to the Clinical Dx Showcase by Daphna Laifenfeld @Genetikaplus on Jan 25th, 2024. Don't miss this illuminating Session S2 starting at 9.00 A.M. More insights at #PMWC24. Details at pmwcintl.com/program

Genetika+ is now NeuroKaire! We're excited to announce our new company name, which embodies the powerful connection between the brain (neuro) and the potential for better outcomes (care/kaire). neurokaire.com #NeuroKaire #precisionmedicine #MentalHealthInnovation

Check out our CEO, Talia Cohen Solal's reflections on the Olympic Games and the immense challenges the olympians face alongside their battle for medals over the coming weeks.

Good to know!

Rosh Hashanah reminds us that every ending is a new beginning. It's a time to reflect, let go of past burdens, and embrace the happiness and possibilities that lie ahead. Happy New Year🍏🍎 🍯 #NeuroKaire

We are excited to be part of the Psych Conference in Boston! Be sure to stop by our booth #1040 from October 29 to November 2. Dive into cutting-edge advancements in psychology and neuroscience, engage in insightful discussions, and discover how we can innovate together!

Still time to connect at ACNP! Stop by poster W71 to hear Dr. Talia Cohen Solal present on “Precision Psychiatry Using hiPSC Neurons: Synaptic Connectivity as a Biomarker for Drug Response.” Let’s transform mental health care together! #ACNP2024 #NeuroKaire #PrecisionPsychiatry

We’ve wrapped up $10M in funding to advance precision medicine tools in mental health. Combined with our recent CLIA certification, this provides incredible momentum heading into 2025! Read more: neurokaire.com/news/neurokair…